|
|||||
|
|
Long-term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors |
|
| Authors: | Geoffrey Hackett Nigel Cole Akhilesh Mulay Richard C. Strange Sudarshan Ramachandran |
| Affiliation: | 1. Department of Urology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK;2. University of Cambridge, Cambridge, UK;3. Institute for Science and Technology in Medicine, Keele University Medical School, Stoke-on-Trent, UK;4. Department of Clinical Biochemistry, University Hospitals of North Midlands/Faculty of Health Sciences, Staffordshire University, Stoke-on-Trent, UK College of Engineering, Design & Physical Sciences, Brunel University London, London, UK |
| Abstract: | |
| Keywords: | type 2 diabetes all-cause mortality testosterone therapy #Hypogonadism #Testosterone #Andrology |